Bekes Megyei Pandy Kalman Korhaz
Gyula H-5700
0 studies enrolling now · 14 studies all time
What they study most
Alzheimer's Disease, Attention-deficit/Hyperactivity Disorder, Autism, Bipolar Depression, Bipolar I Depression, Critical Limb Ischemia, Crohn Disease, Influenza, Lung Cancer, Lupus Erythematosus, Systemic, Lymphoma, Non-Hodgkin, Post-essential Thrombocythemia Myelofibrosis
Studies at this site
- A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
- A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) — Completed
- Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease — Completed
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder — Completed
- Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis — Completed
- BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) — Completed
- Pediatric Open-Label Extension Study — Completed
- Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
- Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia — Stopped early
- Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed
- Lurasidone Pediatric Bipolar Study — Completed
- Pediatric Schizophrenia Efficacy and Safety Study — Completed
- A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis — Completed